Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis.
J A WesselN A DanhofRik Van EekelenMichael P DiamondRichard S LegroK PeeraerThomas M D'HoogheM ErdemT DankertBen J CohlenC ThyagarajuBen-Willem J MolMarian ShowellMadelon van WelyM H MochtarRui WangPublished in: Human reproduction update (2022)
In couples with unexplained infertility undergoing IUI-OS, gonadotrophins increased the chance of a live birth and reduced the time to conception compared to CC, at the cost of a higher multiple pregnancy rate, when not differentiating strategies on cancellation criteria or the starting dose. The treatment effects did not seem to differ in women of different age, BMI or primary versus secondary infertility. In a modern practice where a lower starting dose and stricter cancellation criteria are in place, effectiveness and safety of different agents seem both acceptable, and therefore intervention availability, cost and patients' preferences should factor in the clinical decision-making. As the evidence for comparisons to letrozole is based on one RCT providing IPD, further RCTs comparing letrozole and other interventions for unexplained infertility are needed.
Keyphrases
- polycystic ovary syndrome
- insulin resistance
- decision making
- systematic review
- end stage renal disease
- randomized controlled trial
- pregnancy outcomes
- newly diagnosed
- healthcare
- chronic kidney disease
- peritoneal dialysis
- adipose tissue
- body mass index
- metabolic syndrome
- preterm birth
- magnetic resonance imaging
- type diabetes
- machine learning
- quality improvement
- magnetic resonance
- skeletal muscle
- deep learning
- intimate partner violence
- patient reported outcomes
- gestational age
- smoking cessation